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Summary
For the 2011–2013 incident cohort:
. Patients of non-White ethnicity had an equal chance
of transplant wait-listing within two years of starting
renal replacement therapy (OR 1.03, 95% CI 0.93–
1.14). This represents an improvement in equity of
access to the kidney transplant waiting list com-
pared to ﬁndings from 2008–2010. Once on the
transplant waiting list, non-White patients had a
60% lower chance of receiving a kidney transplant
of any type within two years (OR 0.40, 95% CI
0.35–0.45).
. Compared to men, women had a 17% lower chance
of being activated on the kidney transplant waiting
list within two years of starting renal replacement
therapy (OR 0.83, 95% CI 0.76–0.90). Once on the
transplant waiting list, women had a 15% lower
chance of receiving a kidney transplant of any
type within two years (OR 0.85, 95% CI 0.76–0.96).
. Compared to patients treated at transplanting
centres, patients treated at non-transplanting centres
were less likely to be wait-listed for transplantation
within two years of starting dialysis (OR 0.70, 95%
CI 0.65–0.77), had an equal chance of receiving a
transplant from a donor after brainstem death
within two years of wait-listing (OR 1.06, 95% CI
0.91–1.23), but were less likely to receive a transplant
from a donor after circulatory death or living kidney
donor within two years of wait-listing (OR 0.85, 95%
CI 0.76–0.95). Overall, this equated to a
reduced chance of receiving a transplant from any
donor type for patients treated at non-transplanting
renal centres (OR 0.88, 95% CI 0.78–0.98).
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Introduction
Kidney transplantation is associated with improved
clinical outcomes and quality of life compared to dialysis
[1–3], so is the preferred method of renal replacement
therapy (RRT) for clinically suitable patients. Early trans-
plantation minimises time on dialysis, a factor associated
with reduced graft and patient survival.
Early transplant wait-listing increases the probability
of transplantation from a deceased donor because the
current national kidney allocation scheme [4] prioritises
potential transplant recipients who have accrued more
time on the waiting list. Therefore, renal centres achiev-
ing earlier transplant wait-listing provide their patients
with a clinical advantage.
This analysis aims to evaluate whether access to
transplant wait-listing and access to transplantation is
equitable in the UK. Rates of wait-listing and rates of
transplantation after wait-listing were analysed according
to patient characteristics. Time from starting RRT to
wait-listing was also analysed. Differences between
renal centres and between transplanting versus non-
transplanting renal centres were analysed, with adjust-
ment for patient characteristics.
Methods
Study population
To identify factors which inﬂuence the likelihood of wait-listing
for transplantation, an incident RRT cohort was analysed. All
adult patients (N = 20,675) starting RRT between 1 January
2011 and 31 December 2013 at renal centres (N = 71) returning
data to the UK Renal Registry (UKRR) were considered for
inclusion. Patients aged 65 years and over (N = 10,151), patients
listed for multi-organ transplants other than kidney and pancreas
(N = 33) and patients who were suspended for more than 30 days
within 90 days of wait-listing (N = 593) were excluded. The latter
exclusion avoided any potential bias from centres that may acti-
vate patients on the transplant waiting list and then immediately
suspend them before reactivation after medical assessment of a
patient’s ﬁtness for transplantation. The remaining 9,898 patients
were followed until two years after starting RRT (latest 31 Decem-
ber 2015), until they were registered on the waiting list for a kidney
transplant alone or kidney and pancreas transplant, or until death,
whichever was earliest.
To identify factors which inﬂuence the likelihood of trans-
plantation after wait-listing, patients from the above cohort who
were wait-listed before 31 December 2014 were identiﬁed. These
5,691 patients were followed until two years after wait-listing
(latest 31 December 2016), until they received a kidney transplant
alone or kidney and pancreas transplant, or until death, whichever
was earliest.
Patients transplanted after starting dialysis were assigned to the
renal centre recorded by the UKRR as having provided the dialysis.
For patients transplanted pre-emptively, there may be instances
where the renal centre recorded was the transplanting centre,
even when work-up took place in a non-transplanting centre.
Data analysed
UKRR data included start date of RRT and patient character-
istics including age group (18–29, 30–39, 40–49, 50–59, 60–64
years), sex (male, female), ethnicity (White, non-White, missing),
and primary renal diagnosis (PRD, classiﬁed as: diabetes, other,
missing). Date of wait-listing and date of transplantation were
provided by the UK Transplant Registry, held by the Organ
Donation and Transplantation Directorate of NHS Blood and
Transplant.
Outcomes
Proportion of incident dialysis patients wait-listed within two
years of starting RRT. In addition to patients wait-listed during
the study period, patients who received a living donor transplant
within two years of starting RRT were also considered to have
been wait-listed.
Days from starting RRT to transplant wait-listing. For patients
wait-listed after starting dialysis, time from starting dialysis to
wait-listing was recorded. Patients receiving a pre-emptive trans-
plant (living or deceased donor) were recorded as wait-listed on
the day of transplantation (i.e. time from starting RRT to wait-
listing: zero days). Patients who received a living donor transplant
after starting dialysis who had not been formally wait-listed prior
to transplantation were recorded as wait-listed six months before
the date of their transplant (with a minimum time to wait-listing
of zero days). This aimed to account for the time needed to prepare
patients for a living donor transplant, assuming suitability for
wait-listing six months before living donor transplantation.
Proportion of wait-listed patients receiving a transplant within
two years of wait-listing. Transplants from donors after brainstem
death were considered separately from transplants from donors
after circulatory death or living donors, because of differences in
the process of allocation. Kidneys from donors after brainstem
death are allocated according to national allocation policy, while
kidneys from donors after circulatory death are allocated region-
ally according to the 2006 donor after brainstem death kidney allo-
cation scheme, and one kidney from each donor is offered to the
local transplant centre [4]. The process of living donor transplan-
tation is managed by the transplanting centre (and referring non-
transplanting centre). The overall proportion transplanted from
any donor type was also calculated.
Statistical methods
Logistic regression models were ﬁtted to examine the relation-
ship between patient characteristics (age group, ethnicity, sex,
PRD) and transplant wait-listing within two years of starting
RRT, or receipt of a transplant within two years of wait-listing.
The proportion of all incident RRT patients listed for trans-
plantation within two years of starting RRT and the proportion
of wait-listed patients who were transplanted within two years
were calculated for each renal centre, with adjustment for the
above patient characteristics. Differences in outcome measures
between transplanting and non-transplanting renal centres were
assessed.
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Median time from starting RRT to wait-listing at each renal
centre was estimated by Kaplan-Meier (KM) analysis, censored
at death or on 31 December 2015, whichever was earlier. Conﬁ-
dence intervals of median time to wait-listing by centre were
derived using bootstrapping. In centres where the KM curve did
not reach 50% (and therefore median time could not be calcu-
lated), the ﬁnal event time point was used instead. The effect of
renal centre on time to wait-listing was calculated by including
renal centre as a covariate in a Cox regression model for time to
wait-listing including patients from all centres.
Funnel plots were used to present results for each outcome
variable, providing a visual comparison of the relative perform-
ance of renal centres. Where appropriate, funnel plots were
adjusted for patient characteristics known to inﬂuence each
outcome, based on the results of the logistic regression models
described above. In each funnel plot, the solid thick line indi-
cates the national mean. Dashed lines indicate 95% and 99.8%
conﬁdence intervals, corresponding to two and three standard
deviations from the mean respectively. Each point on the plot
represents one renal centre. For each outcome measure, if no
signiﬁcant inter-centre variation was present, three of 71 renal
centres would be expected to fall between the 95% and 99.8%
conﬁdence intervals and no centre should fall outside the 99.8%
conﬁdence interval. Funnel plots showing the proportion of
patients transplanted at two years after wait-listing excluded
centres with fewer than ten patients wait-listed at the start of the
study period (N = 3).
SAS 9.3 was used for all analyses. A p value below 5% was
considered statistically signiﬁcant. The analysis described is
based on the methodology described in chapter 11 of the UKRR
17th Annual Report [5] and a previous independently peer-
reviewed publication [6].
Results
Access to transplantation by patient characteristics
Table 9.1 shows results of logistic regression analysis
for the relationship between patient characteristics and
the odds of transplant wait-listing within two years of
starting RRT. There were missing ethnicity data for
7.9% of patients and missing PRD data for 4.5%.
The results of logistic regression analyses for the
relationship between patient characteristics and the like-
lihood of receiving a kidney transplant within two years
of wait-listing are shown in table 9.2 (donor after brain-
stem death), table 9.3 (donor after circulatory death or
living kidney donor) and table 9.4 (any donor type). Eth-
nicity data were missing for 7.6% of patients and PRD
data for 3.6%.
Access to transplantation by individual renal centre
After adjusting for patient characteristics (age, ethni-
city, sex, PRD), there were signiﬁcant differences between
renal centres in the proportion of patients wait-listed
within two years of starting RRT (ﬁgure 9.1, table 9.5).
After adjusting for patient characteristics (age, ethni-
city, sex, PRD), there were also signiﬁcant differences
between renal centres in the proportion of patients
receiving a kidney transplant within two years of wait-
listing. This was true for transplants from donors after
Table 9.1. Multivariable logistic regression model showing the relationship between patient characteristics and odds of transplant
wait-listing within two years of starting RRT
Factor Category Patients N (%) Odds ratio 95% CI P value
Age 18–29 818 (8.3) 1 ref n/a
30–39 1,256 (12.7) 0.73 0.59–0.91 0.0046
40–49 2,392 (24.2) 0.48 0.40–0.59 ,0.0001
50–59 3,349 (33.8) 0.28 0.23–0.34 ,0.0001
60–64 2,083 (21.0) 0.14 0.11–0.17 ,0.0001
Ethnicity White 6,613 (66.8) 1 ref n/a
Non-White 2,505 (25.3) 1.03 0.93–1.14 0.54
Missing 780 (7.9) 0.97 0.83–1.14 0.70
Sex Male 6,047 (61.1) 1 ref n/a
Female 3,851 (38.9) 0.83 0.76–0.90 ,0.0001
PRD Not diabetic 6,857 (69.3) 1 ref n/a
Diabetic 2,597 (26.2) 0.47 0.43–0.52 ,0.0001
Missing 444 (4.5) 0.57 0.47–0.70 ,0.0001
ref – reference category; n/a – not applicable
Access to kidney transplantation in the
UK (2011–2013 incident cohort)
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brainstem death (ﬁgure 9.2, table 9.6) and transplants
from donors after circulatory death or living donors
(ﬁgure 9.3, table 9.6). The number of centres falling on
or outside the 99.8% conﬁdence intervals was more
marked in the analysis of transplants from donors after
circulatory death or living kidney donors, with ﬁve falling
above and ten centres below. Overall, this equated to a
signiﬁcant inter-centre difference in the proportion of
patients receiving a transplant from any donor type
within two years of wait-listing (ﬁgure 9.4, table 9.6).
Access to transplantation by transplanting vs
non-transplanting renal centre
Compared to patients treated at transplanting renal
centres, those treated at non-transplanting renal centres:
. Were less likely to be wait-listed within two years of
starting dialysis (OR 0.70, 95% CI 0.65–0.77)
. Had an equal chance of receiving a transplant from
a donor after brainstem death within two years of
wait-listing (OR 1.06, 95% CI 0.91–1.23)
Table 9.2. Multivariable logistic regression model showing the relationship between patient characteristics and odds of receiving a
transplant from a donor after brainstem death within two years of wait-listing
Factor Category Patients N (%) Odds ratio 95% CI P value
Age 18–29 680 (12.0) 1 ref n/a
30–39 954 (16.8) 1.02 0.80–1.30 0.87
40–49 1,578 (27.7) 0.62 0.49–0.78 ,0.0001
50–59 1,745 (30.7) 0.39 0.31–0.50 ,0.0001
60–64 734 (12.9) 0.31 0.23–0.43 ,0.0001
Ethnicity White 3,780 (66.4) 1 ref n/a
Non-White 1,480 (26.0) 0.72 0.60–0.85 0.0002
Missing 431 (7.6) 1.27 0.98–1.65 0.068
Sex Male 3,554 (62.5) 1 ref n/a
Female 2,137 (37.5) 0.95 0.82–1.10 0.50
PRD Not diabetic 4,391 (77.2) 1 ref n/a
Diabetic 1,093 (19.2) 2.55 2.15–3.01 ,0.0001
Missing 207 (3.6) 1.32 0.90–1.95 0.16
ref – reference category; n/a – not applicable
Table 9.3. Multivariable logistic regression model showing the relationship between patient characteristics and the odds of receiving
a transplant from a donor after circulatory death or living kidney donor within two years of wait-listing
Factor Category (at baseline) Patients N (%) Odds ratio 95% CI P value
Age 18–29 680 (12.0) 1 ref n/a
30–39 954 (16.8) 0.66 0.54–0.81 ,0.0001
40–49 1,578 (27.7) 0.51 0.42–0.61 ,0.0001
50–59 1,745 (30.7) 0.50 0.42–0.60 ,0.0001
60–64 734 (12.9) 0.43 0.34–0.53 ,0.0001
Ethnicity White 3,780 (66.4) 1 ref n/a
Non-White 1,480 (26.0) 0.47 0.41–0.54 ,0.0001
Missing 431 (7.6) 0.71 0.58–0.87 0.0012
Sex Male 3,554 (62.5) 1 ref n/a
Female 2,137 (37.5) 0.88 0.79–0.98 0.023
PRD Not diabetic 4,391 (77.2) 1 ref n/a
Diabetic 1,093 (19.2) 0.55 0.48–0.64 ,0.0001
Missing 207 (3.6) 0.66 0.49–0.89 0.0058
ref – reference category; n/a – not applicable
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Table 9.4. Multivariable logistic regression model showing the relationship between patient characteristics and the odds of receiving
a transplant from any donor type (DBD, DCD or living donor) within two years of wait-listing
Factor Category (at baseline) Patients N (%) Odds ratio 95% CI P value
Age 18–29 680 (12.0) 1 ref n/a
30–39 954 (16.8) 0.61 0.49–0.77 ,0.0001
40–49 1,578 (27.7) 0.33 0.27–0.41 ,0.0001
50–59 1,745 (30.7) 0.26 0.21–0.32 ,0.0001
60–64 734 (12.9) 0.21 0.16–0.26 ,0.0001
Ethnicity White 3,780 (66.4) 1 ref n/a
Non-White 1,480 (26.0) 0.40 0.35–0.45 ,0.0001
Missing 431 (7.6) 0.81 0.66–1.00 0.048
Sex Male 3,554 (62.5) 1 ref n/a
Female 2,137 (37.5) 0.85 0.76–0.96 0.0063
PRD Not diabetic 4,391 (77.2) 1 ref n/a
Diabetic 1,093 (19.2) 1.03 0.90–1.19 0.67
Missing 207 (3.6) 0.77 0.57–1.03 0.079
DBD – donor after brainstem death; DCD – donor after circulatory death; ref – reference category; n/a – not applicable
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Fig. 9.1. Proportion of incident 2011–2013 RRT patients wait-
listed prior to, or within two years of starting RRT, by renal centre
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Fig. 9.2. Proportion of incident 2011–2013 RRT patients, listed
by 31 December 2014, who received a transplant from a donor
after brainstem death within two years of wait-listing, by renal
centre
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Fig. 9.3. Proportion of incident 2011–2013 RRT patients, listed
by 31 December 2014, who received a transplant from a donor
after circulatory death or living donor within two years of wait-
listing, by renal centre
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Fig. 9.4. Proportion of incident 2011–2013 RRT patients, listed by
31 December 2014, who received a transplant from any donor type
(donor after brainstem death, donor after circulatory death or liv-
ing donor) within two years of wait-listing, by renal centre
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. Were less likely to receive a transplant from a donor
after circulatory death or living donor within two
years of wait-listing (OR 0.85, 95% CI 0.76–0.95).
Overall, this equated to a reduced chance of receiving a
transplant from any donor type for patients treated at
non-transplanting renal centres (OR 0.88, 95% CI 0.78–
0.98).
Time to transplant wait-listing by renal centre
Table 9.7 shows the median time (days), or the ﬁnal
event time, from starting RRT to wait-listing for each
renal centre. Figure 9.5 shows a funnel plot of time
from starting RRT to wait-listing by renal centre. These
values were derived from simulations based on the actual
data and for six centres (those with fewer events and/or
longer waiting times) median values could not be esti-
mated, so ﬁnal event times are shown.
Table 9.5. Proportion of incident patients in each renal centre wait-listed for a kidney transplant prior to or within two years of
starting RRT
Centre
RRT
N
Wait-listed
at 2 years
N
% wait-listed
Unadjusted Risk-adjusted
England
B Heart 137 78 56.9 57.4
B QEH 328 175 53.4 52.4
Basldn 68 30 44.1 47.7
Bradfd 108 57 52.8 50.3
Brightn 162 77 47.5 47.2
Bristol 218 140 64.2 61.9
Camb 150 101 67.3 62.6
Carlis 46 34 73.9 72.4
Carsh 281 150 53.4 55.1
Chelms 59 33 55.9 55.5
Colchr 36 14 38.9 40.2
Covnt 146 77 52.7 49.9
Derby 116 54 46.6 47.6
Donc 71 41 57.7 58.9
Dorset 83 51 61.4 61.7
Dudley 71 23 32.4 33.0
Exeter 116 71 61.2 62.6
Glouc 75 39 52.0 52.7
Hull 124 62 50.0 51.8
Ipswi 56 26 46.4 45.1
Kent 161 94 58.4 59.0
L Barts 495 269 54.3 52.1
L Guys 221 114 51.6 51.8
L Kings 229 90 39.3 40.0
L Rfree 357 229 64.1 60.9
L St.G 132 81 61.4 62.4
L West 530 369 69.6 70.5
Leeds 252 139 55.2 53.3
Leic 383 230 60.1 60.8
Liv Ain 81 30 37.0 38.3
Liv Roy 174 77 44.3 41.8
M RI 294 187 63.6 62.3
Middlbr 158 108 68.4 68.7
Newc 159 83 52.2 51.0
Norwch 95 46 48.4 47.1
Nottm 145 89 61.4 60.9
Oxford 263 181 68.8 70.0
Centre
RRT
N
Wait-listed
at 2 years
N
% wait-listed
Unadjusted Risk-adjusted
Plymth 68 43 63.2 65.0
Ports 264 173 65.5 66.6
Prestn 205 103 50.2 50.5
Redng 132 78 59.1 62.1
Salford 198 117 59.1 64.6
Sheff 203 119 58.6 59.0
Shrew 76 28 36.8 40.1
Stevng 181 118 65.2 62.8
Sthend 41 30 73.2 68.4
Stoke 100 49 49.0 51.2
Sund 87 39 44.8 45.5
Truro 51 36 70.6 70.5
Wirral 69 35 50.7 53.2
Wolve 124 56 45.2 44.3
York 71 41 57.7 56.0
N Ireland
Antrim 32 15 46.9 48.9
Belfast 121 74 61.2 56.9
Newry 31 13 41.9 45.5
Ulster 33 14 42.4 45.8
West NI 36 18 50.0 45.4
Scotland
Abrdn 78 37 47.4 50.2
Airdrie 79 49 62.0 63.1
D & Gall 15 9 60.0 55.7
Dundee 59 26 44.1 45.7
Edinb 145 74 51.0 51.8
Glasgw 256 175 68.4 69.4
Inverns 23 15 65.2 65.9
Klmarnk 50 24 48.0 50.8
Krkcldy 49 22 44.9 49.6
Wales
Bangor 20 4 20.0 23.4
Cardff 234 125 53.4 54.5
Clwyd 17 6 35.3 35.7
Swanse 131 59 45.0 46.4
Wrexm 39 14 35.9 38.0
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Discussion
Patient characteristics and access to transplantation
Increasing patient age was associated with reducing
odds of wait-listing and of transplantation from any
donor type. This is an expected ﬁnding because of the
effect of age on the risks and beneﬁts of transplantation:
older age is associated with increasing comorbidity and
therefore increased clinical risk of transplantation, while
the potential beneﬁt of transplantation in extending life
reduces with increasing age. Older patients who are
suitable for transplantation would be expected to have
increased comorbidity and therefore require more screen-
ing investigations before being wait-listed, reducing the
chance of wait-listing within two years of starting RRT.
Reduced odds of receiving a transplant from a donor
after brainstem death in older patients reﬂects the role
of age in the national kidney allocation scheme [4].
Table 9.7. Median time (days), or ﬁnal event time∗, from starting RRT to transplant wait-listing by renal centre
Centre
RRT
N
Wait-listed
at 2 years
N
Median time
to listing
(days)
Final event
time
(days∗)
England
B Heart 137 84 385
B QEH 328 187 466
Basldn 68 32 854
Bradfd 108 61 489
Brightn 162 82 750
Bristol 218 143 176
Camb 150 107 2
Carlis 46 34 93
Carsh 281 170 480
Chelms 59 36 402
Colchr 36 16 787
Covnt 146 86 511
Derby 116 59 748
Donc 71 45 250
Dorset 83 52 266
Dudley 71 27 n/a 1,095
Exeter 116 72 337
Glouc 75 42 538
Hull 124 66 623
Ipswi 56 28 865
Kent 161 102 349
L Barts 495 299 509
L Guys 221 122 512
L Kings 229 98 n/a 1,064
L Rfree 357 251 188
L St.G 132 91 260
L West 530 391 223
Leeds 252 149 308
Leic 383 240 147
Liv Ain 81 35 869
Liv Roy 174 84 914
M RI 294 196 244
Middlbr 158 116 148
Newc 159 95 535
Norwch 95 48 622
Nottm 145 93 126
Oxford 263 191 125
Centre
RRT
N
Wait-listed
at 2 years
N
Median time
to listing
(days)
Final event
time
(days∗)
Plymth 68 46 213
Ports 264 181 147
Prestn 205 110 589
Redng 132 81 372
Salford 198 122 256
Sheff 203 127 300
Shrew 76 30 n/a 1,252
Stevng 181 124 198
Sthend 41 30 107
Stoke 100 53 387
Sund 87 44 796
Truro 51 39 105
Wirral 69 38 483
Wolve 124 61 965
York 71 41 179
N Ireland
Antrim 32 16 482
Belfast 121 78 232
Newry 31 18 911
Ulster 33 15 1,100
West NI 36 19 436
Scotland
Abrdn 78 40 615
Airdrie 79 51 351
D & Gall 15 9 214
Dundee 59 32 855
Edinb 145 79 507
Glasgw 256 179 162
Inverns 23 16 231
Klmarnk 50 26 441
Krkcldy 49 23 633
Wales
Bangor 20 5 n/a 1,283
Cardff 234 132 330
Clwyd 17 6 n/a 512
Swanse 131 60 719
Wrexm 39 15 n/a 958
n/a – not applicable
∗Final event time given for centres where median time could not be estimated
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In analyses adjusted for age, ethnicity and PRD, female
sex was associated with a reduced chance of transplant
wait-listing within two years of starting RRT (OR 0.83;
95%CI: 0.76–0.90), reduced chance of DCD/living
donor transplant within two years of wait-listing (OR
0.88; 95% CI: 0.79–0.98), and reduced chance of any
transplant within two years of wait-listing (OR 0.85;
95% CI: 0.76–0.96). As would be expected, there was no
signiﬁcant difference by sex in the odds of transplan-
tation from a donor after brainstem death within two
years of wait-listing (OR 0.95; 95% CI: 0.82–1.10).
While previous reports have not always shown signiﬁcant
differences in wait-listing or transplantation by sex, when
there have been differences, women have been shown to
be at a relative disadvantage. This ﬁnding needs validat-
ing in an extended, multi-year UK cohort with data on
comorbidity, but if conﬁrmed clearly needs work to
explore possible explanations.
Patients with diabetes as their PRD were less likely to
be wait-listed within two years of starting RRT, and less
likely to receive a transplant from a donor after circula-
tory death/living donor within two years of wait-listing.
Higher prevalence of comorbidity amongst patients
with diabetes may preclude transplantation or lengthen
the medical evaluation process, explaining this ﬁnding.
Patients with diabetes as their PRD were found to be
more likely to receive a transplant from a donor after
brainstem death once on the waiting list. This is likely
to reﬂect the prioritisation of dual organ transplantation
in organ allocation policy, in addition to the increase in
the number of simultaneous kidney pancreas transplants
during the study period. There was no overall difference
by diabetic status in the likelihood of transplantation at
two years after wait-listing when all donor types were
considered.
As in the 19th Annual Report [7], non-White ethnicity
did not signiﬁcantly inﬂuence the likelihood of wait-
listing (OR 1.03; 95% CI: 0.93–1.15). There was a persist-
ing effect of non-White ethnicity in reducing the chance
of transplantation from a donor after brainstem death
within two years of wait-listing, with a similar magnitude
to analysis from 2013–2015 (OR 0.72; 95% CI: 0.60–0.85
compared to OR 0.79; 95% CI: 0.65–0.95) [7]. This effect
remained smaller than the one observed on the incident
2008–2010 cohort (OR 0.65; 95% CI: 0.52–0.81) [5].
This may reﬂect changes in the efﬁciency of preparation
for transplant wait-listing (for instance, earlier com-
pletion of pre-transplant investigations for patients with
diabetes, who were more likely to have non-White ethni-
city), changes in the demographics of potential transplant
recipients with non-White ethnicity, and alterations in
the national kidney allocation scheme, which now has
less strict criteria in relation to human leucocyte antigen
(HLA) matching [4]. The latter change means that
recipients with non-White ethnicity were less likely to
be disadvantaged by the relative lack of organs from
non-White donors. There was persisting differences by
ethnicity in rates of transplantation from a donor after
circulatory death/living donor. It should be noted that
differences in socioeconomic status between ethnic
groups have previously been found to account for some
of the difference in access to transplantation by ethnicity
[8, 9]. Lack of adjustment for socioeconomic status
therefore limits the reliability of these results. The
UKRR is collaborating with the Access to Transplant
and Transplant Outcome Measures (ATTOM) study,
whose forthcoming results include analyses with detailed
adjustment for comorbidity and individual level socio-
economic status.
When interpreting the analyses in this chapter it is also
important to consider the potential impact of missing
data on the results. Data were missing either because a
renal centre failed to complete relevant ﬁelds on their
renal IT system or from a failure to extract this data.
Missing data may not be at random: patients with
increased comorbidity are likely to die sooner, allowing
inadequate time for their physician to enter relevant
comorbidity data. The very process of working up and
listing a patient makes it less likely that data will be
missing. It is therefore perhaps not surprising that
patients on the national kidney transplant waiting list
were more likely to have ethnicity and PRD data reported
(p , 0.0001)
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Centre variation in access to transplantation
The analyses presented here suggest signiﬁcant inter-
centre variation in access to the transplant waiting list
and access to transplantation, after adjustment for patient
demographics and PRD. However, such results should be
interpreted with caution. Adjustment for comorbidity
included only diabetes as a PRD. Other comorbidities,
unaccounted for in these analyses, may also preclude or
delay wait-listing and transplantation. Adjustment for
several other factors known to inﬂuence access to trans-
plantation, including socioeconomic status, PRD other
than diabetes, comorbidity, and HLA sensitisation was
not performed. Whilst the processes of wait-listing or
transplantation from a donor after circulatory death/liv-
ing donor are directly inﬂuenced by individual centre
practice, the allocation of transplants from donors after
brainstem death is controlled by the national kidney allo-
cation scheme. Therefore, rates of transplantation from
donors after brainstem death should be relatively inde-
pendent of centre practice differences (except for vari-
ation in the acceptance criteria of individual clinicians).
As such, the persistence of signiﬁcant inter-centre vari-
ation in rates of transplantation from donors after brain-
stem death is consistent with under-adjustment for
patient factors.
After adjustment for patient characteristics, patients
treated at transplanting renal centres had increased access
to transplant wait-listing and to transplantation from a
donor after circulatory death or living donor. There was
no difference in access to transplants from donors after
brainstem death once patients were wait-listed. These
have been consistent ﬁndings in UKRR analyses since
2010, suggesting that reduced contact with clinicians
directly involved in transplantation and increased geo-
graphical distance to transplanting centres reduces access
to transplantation. This analysis may be subject to bias by
lack of conclusive adjustment for patient characteristics
as well as the allocation of patients receiving a pre-
emptive transplant to their transplanting centre, even if
the work-up had been initiated in a timely fashion by
the non-transplanting centre. Lastly, there was compe-
tition between the two outcome variables (transplant
from a donor after brainstem death versus transplant
from a donor after circulatory death/living donor). As
such, patients from centres with a higher rate of trans-
plantation from a donor after circulatory death/living
donor may have reduced odds of transplantation from
a donor after brainstem death (and vice versa).
These issues will be addressed in future analyses, allo-
cating patients according to their location of residence
(rather than their treatment centre), and using method-
ology which accounts for competing risk. In addition,
the results of analyses from the ATTOM study with
more detailed adjustment for case mix are forthcoming.
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